Get started
DR REDDYS LABSDR REDDYS LABSDR REDDYS LABS

DR REDDYS LABS

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast Options

DRREDDY chart

Key stats

Market capitalization
‪1.01 T‬INR
Dividend yield (indicated)
0.66%
Price to earnings Ratio (TTM)
19.30
Basic EPS (TTM)
313.75INR
Net income
‪45.07 B‬INR
Revenue
‪245.88 B‬INR
Shares float
‪121.92 M‬
Beta (1Y)
0.29

About DR REDDYS LABS

Sector
Health Technology
CEO
Erez Israeli
Headquarters
Hyderabad
Website
drreddys.com
Employees (FY)
‪25.86 K‬
Founded
1984
ISIN
INE089A01023
FIGI
BBG000CQND59
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DRREDDY is 5925.55 INR — it has decreased by 0.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange DR REDDYS LABS stocks are traded under the ticker DRREDDY.
DR REDDYS LABS is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
DRREDDY stock is 1.69% volatile and has beta coefficient of 0.29. Check out the list of the most volatile stocks — is DR REDDYS LABS there?
One year price forecast for DR REDDYS LABS has a max estimate of 6785.00 INR and a min estimate of 3920.00 INR.
DRREDDY earnings for the last quarter are 88.78 INR whereas the estimation was 72.46 INR which accounts for 22.52% surprise. Estimated earnings for the next quarter are 73.40 INR. See more details about DR REDDYS LABS earnings.
DR REDDYS LABS revenue for the last quarter amounts to ‪68.80 B‬ INR despite the estimated figure of ‪67.85 B‬ INR. In the next quarter revenue is expected to reach ‪69.29 B‬ INR.
Yes, you can track DR REDDYS LABS financials in yearly and quarterly reports right on TradingView.
DRREDDY stock has fallen by 3.94% compared to the previous week, the month change is a 3.26% fall, over the last year DR REDDYS LABS has showed a 20.54% increase.
DRREDDY net income for the last quarter is ‪13.79 B‬ INR, while the quarter before that showed ‪14.80 B‬ INR of net income which accounts for −6.83% change. Track more DR REDDYS LABS financial stats to get the full picture.
Today DR REDDYS LABS has the market capitalization of ‪1.01 T‬, it has decreased by 1.02% over the last week.
Yes, DRREDDY dividends are paid annually. The last dividend per share was 40.00 INR. As of today, Dividend Yield (TTM)% is 0.66%. Tracking DR REDDYS LABS dividends might help you take more informed decisions.
DR REDDYS LABS dividend yield was 0.87% in 2022, and payout ratio reached 14.74%. The year before the numbers were 0.70% and 21.12% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, DRREDDY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR REDDYS LABS stock right from TradingView charts — choose your broker and connect to your account.
DRREDDY reached its all-time high on Feb 28, 2024 with the price of 6505.90 INR, and its all-time low was 122.05 INR and was reached on Jan 1, 1999.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪25.86 K‬ employees. See our rating of the largest employees — is DR REDDYS LABS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR REDDYS LABS technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR REDDYS LABS stock shows the buy signal. See more of DR REDDYS LABS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DR REDDYS LABS future price: according to them, DRREDDY price has a max estimate of 6785.00 INR and a min estimate of 3920.00 INR. Read a more detailed DR REDDYS LABS forecast: see what analysts think of DR REDDYS LABS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR REDDYS LABS EBITDA is ‪74.92 B‬ INR, and current EBITDA margin is 26.38%. See more stats in DR REDDYS LABS financial statements.